Clinical trial
A Safety and Efficacy Study in Patients With Gastric Cancer
NCT00400179 · Taiho Oncology, Inc., Industry · Completed
Key facts
| NCT number | NCT00400179 |
|---|---|
| Title | A Safety and Efficacy Study in Patients With Gastric Cancer |
| Official title | An Open-Label Multicenter, Randomized, Phase 3 Study of S-1 in Combination With Cisplatin Against 5-Fu in Combination W/ Cisplatin in Patients W/ Advanced Gastric Cancer Previously Untreated W/ Chemotherapy for Advanced Disease |
| Lead sponsor | Taiho Oncology, Inc., Industry |
| Collaborators | Quintiles, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Gastric Cancer |
| Intervention type | Drug |
| Interventions | S-1/Cisplatin, 5-FU/cisplatin |
| Enrollment | 1,053 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Nov 16, 2006 |
| Last update posted | Sep 19, 2024 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: